These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33532640)

  • 1. Potential compounds from several Indonesian plants to prevent SARS-CoV-2 infection: A mini-review of SARS-CoV-2 therapeutic targets.
    Illian DN; Siregar ES; Sumaiyah S; Utomo AR; Nuryawan A; Basyuni M
    Heliyon; 2021 Jan; 7(1):e06001. PubMed ID: 33532640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular docking and dynamics studies of Nicotinamide Riboside as a potential multi-target nutraceutical against SARS-CoV-2 entry, replication, and transcription: A new insight.
    Esam Z; Akhavan M; Lotfi M; Bekhradnia A
    J Mol Struct; 2022 Jan; 1247():131394. PubMed ID: 34483364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.
    Wu C; Liu Y; Yang Y; Zhang P; Zhong W; Wang Y; Wang Q; Xu Y; Li M; Li X; Zheng M; Chen L; Li H
    Acta Pharm Sin B; 2020 May; 10(5):766-788. PubMed ID: 32292689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of SARS-CoV-2 3CL
    Tahir Ul Qamar M; Alqahtani SM; Alamri MA; Chen LL
    J Pharm Anal; 2020 Aug; 10(4):313-319. PubMed ID: 32296570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based virtual screening of bioactive compounds from Indonesian medical plants against severe acute respiratory syndrome coronavirus-2.
    Gani MA; Nurhan AD; Maulana S; Siswodihardjo S; Shinta DW; Khotib J
    J Adv Pharm Technol Res; 2021; 12(2):120-126. PubMed ID: 34159141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2.
    Chen W; Wang Z; Wang Y; Li Y
    Front Pharmacol; 2021; 12():702472. PubMed ID: 34483904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plants-Derived Biomolecules as Potent Antiviral Phytomedicines: New Insights on Ethnobotanical Evidences against Coronaviruses.
    Siddiqui AJ; Danciu C; Ashraf SA; Moin A; Singh R; Alreshidi M; Patel M; Jahan S; Kumar S; Alkhinjar MIM; Badraoui R; Snoussi M; Adnan M
    Plants (Basel); 2020 Sep; 9(9):. PubMed ID: 32967179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plant Metabolites as SARS-CoV-2 Inhibitors Candidates: In Silico and In Vitro Studies.
    Lopes AJO; Calado GP; Fróes YN; Araújo SA; França LM; Paes AMA; Morais SV; Rocha CQD; Vasconcelos CC
    Pharmaceuticals (Basel); 2022 Aug; 15(9):. PubMed ID: 36145266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based virtual screening and molecular dynamics of phytochemicals derived from Saudi medicinal plants to identify potential COVID-19 therapeutics.
    Alamri MA; Altharawi A; Alabbas AB; Alossaimi MA; Alqahtani SM
    Arab J Chem; 2020 Sep; 13(9):7224-7234. PubMed ID: 34909058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicinal Plants as Sources of Active Molecules Against COVID-19.
    Benarba B; Pandiella A
    Front Pharmacol; 2020; 11():1189. PubMed ID: 32848790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural medicinal plant products as an immune-boosters: A possible role to lessen the impact of Covid-19.
    Islam SS; Midya S; Sinha S; Saadi SMAI
    Case Stud Chem Environ Eng; 2021 Dec; 4():100105. PubMed ID: 38620656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavonoids: A complementary approach to conventional therapy of COVID-19?
    Solnier J; Fladerer JP
    Phytochem Rev; 2021; 20(4):773-795. PubMed ID: 32982616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2.
    Drak Alsibai K
    Med Hypotheses; 2020 Oct; 143():109893. PubMed ID: 32512290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of natural products towards the SARS-CoV-2: A critical review.
    Raman K; Rajagopal K; Islam F; Dhawan M; Mitra S; Aparna B; Varakumar P; Byran G; Choudhary OP; Emran TB
    Ann Med Surg (Lond); 2022 Aug; 80():104062. PubMed ID: 35814035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection.
    Goyal RK; Majeed J; Tonk R; Dhobi M; Patel B; Sharma K; Apparsundaram S
    Rev Cardiovasc Med; 2020 Sep; 21(3):365-384. PubMed ID: 33070542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in the Discovery of Potent Proteases Inhibitors Targeting the SARS Coronaviruses.
    Sharma A; Kaliya K; Maurya SK
    Curr Top Med Chem; 2021; 21(4):307-328. PubMed ID: 33183205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
    Choudhury A; Mukherjee S
    J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview on medicinal plants used for combating coronavirus: Current potentials and challenges.
    Abou Baker DH; Hassan EM; El Gengaihi S
    J Agric Food Res; 2023 Sep; 13():100632. PubMed ID: 37251276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship Between COVID-19 and Angiotensin-Converting Enzyme 2: A Scoping Review.
    Shojaee A; Vahedian-Azimi A; Faizi F; Rahimi-Bashar F; Shahriary A; Galeh HEG; Nehrir B; Guest PC; Sahebkar A
    Adv Exp Med Biol; 2021; 1321():53-68. PubMed ID: 33656713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.